Page last updated: 2024-09-04

levofloxacin and Infections, Ureaplasma

levofloxacin has been researched along with Infections, Ureaplasma in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Crabb, DM; Duffy, LB; Waites, KB2
Davies, RL; Jones, LC; Morris, DJ; Portal, E; Sands, K; Spiller, OB1
Macía, M; Navarro, D; Romay, AB; Trastoy, R; Treviño, M; Veiga, E1
Beeton, ML; Chalker, VJ; Jones, LC; Maxwell, NC; Spiller, OB1
Biernat-Sudolska, M; Drzewiecki, A; Rojek-Zakrzewska, D1
Hashimoto, J; Hayashi, K; Ichihara, K; Iwasawa, A; Kurimura, Y; Satoh, T; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T1
Liu, JY; Luo, DQ; Wu, YM; Yang, W; Yu, MJ; Zhang, B1
Dan, M; Rosenberg, S; Samra, Z1
Crabb, DM; Duffy, LB; Glass, JI; Paralanov, V; Waites, KB; Xiao, L1

Other Studies

10 other study(ies) available for levofloxacin and Infections, Ureaplasma

ArticleYear
Comparative in vitro activities of the investigational fluoroquinolone DC-159a and other antimicrobial agents against human mycoplasmas and ureaplasmas.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aminopyridines; Anti-Bacterial Agents; Fluoroquinolones; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma hominis; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections

2008
Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolide, CEM-101.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Ketolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma fermentans; Mycoplasma genitalium; Mycoplasma Infections; Mycoplasma pneumoniae; Ureaplasma; Ureaplasma Infections

2009
MYCO WELL D-ONE detection of Ureaplasma spp. and Mycoplasma hominis in sexual health patients in Wales.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2020, Volume: 39, Issue:12

    Topics: Drug Resistance, Multiple, Bacterial; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Mycoplasma hominis; Mycoplasma Infections; Sexual Health; Tetracycline; Ureaplasma; Ureaplasma Infections; Wales

2020
Prevalence of genital Mycoplasma and response to eradication treatment in patients undergoing assisted reproductive techniques.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Clindamycin; Doxycycline; Embryo Implantation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Levofloxacin; Male; Middle Aged; Moxifloxacin; Mycoplasma hominis; Mycoplasma Infections; Prevalence; Real-Time Polymerase Chain Reaction; Reproductive Techniques, Assisted; Semen Analysis; Sex Factors; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Young Adult

2019
Antibiotic Resistance among Clinical Ureaplasma Isolates Recovered from Neonates in England and Wales between 2007 and 2013.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:1

    Topics: Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; England; Epidemiological Monitoring; Fluoroquinolones; Gentamicins; Humans; Infant; Infant, Newborn; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Retrospective Studies; Tetracycline; Ureaplasma; Ureaplasma Infections; Wales

2016
[Voice on the treatment of ureaplasmas infections].
    Przeglad epidemiologiczny, 2009, Volume: 63, Issue:1

    Topics: Anti-Infective Agents; Azithromycin; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Ureaplasma; Ureaplasma Infections; Ureaplasma urealyticum

2009
Clinical efficacy of levofloxacin 500 mg once daily for 7 days for patients with non-gonococcal urethritis.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Chlamydia Infections; Chlamydia trachomatis; Humans; Leukocyte Count; Levofloxacin; Male; Middle Aged; Mycoplasma genitalium; Mycoplasma Infections; Ofloxacin; Treatment Outcome; Ureaplasma Infections; Ureaplasma urealyticum; Urethritis; Young Adult

2011
In vitro activities of erythromycin, tetracycline and levofloxacin alone and in dual combinations against ureaplasma spp.
    Chemotherapy, 2011, Volume: 57, Issue:2

    Topics: Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Erythromycin; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Tetracycline; Ureaplasma; Ureaplasma Infections

2011
Susceptibility of Ureaplasma urealyticum to tetracycline, doxycycline, erythromycin, roxithromycin, clarithromycin, azithromycin, levofloxacin and moxifloxacin.
    Journal of chemotherapy (Florence, Italy), 2011, Volume: 23, Issue:2

    Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Dose-Response Relationship, Drug; Doxycycline; Erythromycin; Female; Fluoroquinolones; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Reproducibility of Results; Roxithromycin; Tetracycline; Time Factors; Ureaplasma Infections; Ureaplasma urealyticum

2011
Chromosomal mutations responsible for fluoroquinolone resistance in Ureaplasma species in the United States.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Anti-Bacterial Agents; Chromosomes, Bacterial; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Humans; Isoenzymes; Levofloxacin; Longitudinal Studies; Microbial Sensitivity Tests; Mutation; Ofloxacin; Sequence Analysis, DNA; United States; Ureaplasma; Ureaplasma Infections

2012